MBGH Reports
Transforming Pharmacy Benefits: The Role of Biosimilars, MBGH Report, June 2020
Precision Medicine in Pharmacy Design: Pharmacogenomics & Pharmacogenetics, MBGH, October 2020
Specialty Drug/PBM Reports
Shared Savings Demonstration for Biosimilars in Medicare: An Opportunity to Promote Biologic Drug Competition, Matrix Global Advisors, May 2020
IBM Watson Health Report: The importance of early key opinion leader outreach in the biologics and biosimilars marketplace, IBM Watson Health, July 2019
Carving Out Specialty Pharmacy and Using Biosimilars to Control Specialty Spend, Pfizer Vivio and Dean Foods, 2019
CVS Trends Report 2020 Highlights Upcoming Changes in Health Care Industry, Pharmacy Times, January 2020
CVS Specialty Pharmacy Pipeline, Drugs to Watch: Anticipated Launches Q4 2019 – Q1 2020
Prime Therapeutics Prime Insights: Give up on Biosimilars? Never! February 20, 2020
Optum RxTrends to Watch in 2020
2019 Magellan Rx Management, Medical Pharmacy Trend Report (Tenth Edition)
PBMI Specialty Drug Benefits Reports – 2017, 2018, 2019 Registration required to access this report
PBMI Drug Benefits Reports – 2017, 2018 Registration required to access this report
2018 EMD Serono Specialty Digest (14th Edition)
Industry Reports
2020 Employer Rx Value, National Alliance of Healthcare Purchaser Coalitions
Medical Cost Trend: Behind the Numbers 2020, Health Research Institute, PwC
Global Medicine Spending and Usage Trends: Outlook to 2024, IQVIA Institute Report
Mercer’s 2019 National Survey of Employer-Sponsored Health Plans: Summary
2019 Willis Towers Watson Best Practices in Health Care Employer Survey: Targeting Specialty Drugs
2019 Economic Report on US Pharmacies and Pharmacy Benefit Managers, Pembroke Consulting
Global Oncology Trends 2019, IQVIA Institute Report
The Value of Biosimilars, Improving Treatment Access and Lowering Costs National Alliance, July 2018